Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
TwinStrand Biosciences, Inc., headquartered in the United States, is a pioneering entity in the research and development services sector, specifically within the realm of genomic technologies. Founded in 2016, the company has rapidly established itself as a leader in the development of unique, ultra-sensitive DNA sequencing technologies that enhance the accuracy of genomic analysis.
With a focus on advancing precision medicine, TwinStrand offers innovative products and services that cater to both academic and clinical research markets. Their proprietary technology, known as Duplex Sequencing, stands out for its ability to detect rare genetic variants with unparalleled sensitivity. This positions TwinStrand at the forefront of genomic research, contributing significantly to advancements in cancer genomics and other critical areas. The company’s commitment to innovation and excellence has garnered recognition within the industry, solidifying its reputation as a key player in the evolving landscape of genomic science.
-20 vs industry average
TwinStrand Biosciences, Inc.’s score of 13 is lower than 24% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for TwinStrand Biosciences, Inc. yet.
TwinStrand Biosciences, Inc., based in the US and operating in the Research and development services (73) industry, has not yet publicly disclosed its carbon emissions data. Consequently, specific details regarding their Scope 1, 2, or 3 emissions, or any calculated total emissions, are unavailable.
Without disclosed emissions figures, it is not possible to detail their climate commitments, reduction targets, or achievements. As a company in the research and development sector, their environmental impact may be influenced by laboratory operations, energy consumption, supply chain activities, and business travel. Future disclosures will provide insight into their carbon footprint and their strategies for climate mitigation.
No climate goals have been disclosed for TwinStrand Biosciences, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more